Search Results For
Result: NaN items
Page Results
Investment Strategy
Found: 5 items
Articles
Found: 38 items
Investing in the Bioinformatic Space: It's Not Just the Software - Hardware Counts, Too
Disruptive Innovation: Open Source Synthetic Biology
White papers
Found: 2 items
Podcasts
Found: 25 items
CRISPR Controversy – A conversation with Stanford Prof. Henry Greely
Asking Different Questions Than Everyone Else, with Sean George
Videos
Found: 4 items
Not Your Traditional Investment Firm
ARK is an investment manager focused solely on disruptive innovation. Rooted in over 40 years of experience, we aim to identify large-scale investment opportunities in the public markets resulting from technological innovations centered around DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology. Learn why we believe innovation is key to growth and what sets us apart from other investment firms.
BIS2020 Vol. II: CRISPR Talk with Jennifer Doudna
On June 24th ARK hosted BIS2020 Volume II, a live Q&A video conference that brought together a group of experts from our research ecosystem. In Session 3, Jennifer Doudna, co-inventor of CRISPR Genome Editing answers our questions on the future of health care.